This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Eton Pharmaceuticals’s 8K filing here.
Eton Pharmaceuticals Company Profile
Eton Pharmaceuticals, Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1.
Featured Stories
- Five stocks we like better than Eton Pharmaceuticals
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- Russell 2000 Index, How Investors Use it For Profitable Trading
- These are the 3 Stocks Most Likely to Split in 2025
